Pfizer to ship 13 million doses of COVID-19 vaccine per week to US in mid-March, executive says

(Reuters) – Pfizer Inc. expects to deliver more than 13 million weekly doses of its COVID-19 vaccine to the United States by mid-March, more than double its shipments in early February, a senior Pfizer executive said in a statement prepared witness of a hearing on Tuesday in Congress.

Pfizer has shipped about 40 million doses to U.S. locations so far and is on track to deliver 120 million doses of its two-dose regimen by the end of March, said John Young, Pfizer’s commercial director.

He added that Pfizer is also poised to provide a total of 300 million shots in the U.S. by the end of July and has raised global production expectations for 2021 to at least 2 billion doses.

In his own prepared remarks, the president of Moderna Inc., Stephen Hoge, said the drug maker plans to administer 100 million doses of its dosage by the end of March and 300 million by the end of July.

Johnson & Johnson believes it will be able to ship at least 20 million doses of its single dose to the United States by the end of March after receiving U.S. regulatory authorization, said Vice President of Medicine Richard Nettles. It is expected to send 100 million doses by mid-2021, he said.

Drug manufacturers’ statements put the United States on track to receive 240 million doses by the end of March, enough to inoculate 130 million Americans and 700 million doses by mid-year, more than enough to dose the entire northern population. -americana.

The comments were prepared ahead of a hearing in the U.S. Congress on vaccine availability to be held by the House Committee on Energy and Commerce on Tuesday.